Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-24-004407

Interim President and CEO gave up 3,223 shares (to pay taxes)

  • Interim President and CEO acquired 9,466 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Walker Neal Interim President and CEO 2024-03-01 Option exercise +9,466 1,282,668 D: show line 1 in the form
Walker Neal Interim President and CEO 2024-03-01 Shares withheld for taxes −3,223 $1.24 $3,997 1,279,445 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Walker Neal Interim President and CEO 2024-03-01 Option exercise · Restricted Stock Units −9,466 132,534 D: show line 3 in the form
Loading xslF345X05/doc4.xml…